Literature DB >> 1359696

Tissue distribution of neutrophils in postischemic acute renal failure.

C C Willinger1, H Schramek, K Pfaller, W Pfaller.   

Abstract

Polymorphonuclear neutrophil granulocytes (PMNs) seem to participate in the pathogenesis of renal ischemic reperfusion injury. The kidneys from male Sprague Dawley rats were immersion-fixed after 45 min of renal artery clamping followed by reperfusion for 0, 5, 20, and 120 min, respectively. The tissue distribution of PMNs in the kidneys was studied histochemically using naphthol AS-D chloroacetate esterase as a specific marker for these cells. Neutrophil counts per unit sectional area were obtained for renal cortex, outer and inner medulla. In the cortex separate intraglomerular and peritubular counts, and in the outer medulla separate outer and inner stripe counts were made. After 120 min of reperfusion the total renal PMN counts were 488 +/- 62 (n = 4) compared with 54 +/- 4 (n = 4) per cm2 in nonischemic controls. Within 120 min of reperfusion PMN counts increased by a factor of 8 in the cortex, of 12 in the outer medulla and of 14 in the inner medulla, compared with controls. The ratio of intraglomerular against peritubular PMN counts was approximately 2 in controls, but 0.5 after a 120-min reperfusion interval. The outer stripe of the outer medulla contained only a small number of PMNs whereas PMN counts of 923 +/- 197 (n = 4) per cm2 were found in the inner stripe after 120 min reperfusion. Interestingly, there was a marked increase in PMNs in the inner stripe during the first 5 min of reperfusion but no extravasation of PMNs was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359696     DOI: 10.1007/bf02899687

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  9 in total

Review 1.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Type I interferon pathway mediates renal ischemia/reperfusion injury.

Authors:  Maria Cecilia S Freitas; Yoichiro Uchida; Charles Lassman; Gabriel M Danovitch; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-07-27       Impact factor: 4.939

Review 3.  Pathophysiology of acute kidney injury.

Authors:  David P Basile; Melissa D Anderson; Timothy A Sutton
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

4.  Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury.

Authors:  Wesley M Raup-Konsavage; Yanming Wang; Wei Wei Wang; Denis Feliers; Hong Ruan; W Brian Reeves
Journal:  Kidney Int       Date:  2017-10-20       Impact factor: 10.612

5.  Annexin 1 mimetic peptide protects against renal ischemia/reperfusion injury in rats.

Authors:  Fernando N Facio; Angela A Sena; Leandro P Araújo; Gloria E Mendes; Isac Castro; Marcus A M Luz; Luis Yu; Sonia Maria Oliani; Emmanuel A Burdmann
Journal:  J Mol Med (Berl)       Date:  2010-10-16       Impact factor: 4.599

6.  Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.

Authors:  H Chiao; Y Kohda; P McLeroy; L Craig; I Housini; R A Star
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 7.  Slit2-Robo signaling in inflammation and kidney injury.

Authors:  Swasti Chaturvedi; Lisa A Robinson
Journal:  Pediatr Nephrol       Date:  2014-04-29       Impact factor: 3.714

Review 8.  Leukocyte recruitment and acute renal failure.

Authors:  Kai Singbartl; Klaus Ley
Journal:  J Mol Med (Berl)       Date:  2003-12-10       Impact factor: 4.599

9.  Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction.

Authors:  Xiangyang Dong; Lori A Bachman; Melinda N Miller; Karl A Nath; Matthew D Griffin
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.